TruthArchive.ai - Related Video Feed

In the presented remarks, the speaker engages the audience with a series of questions intended to reveal potential overlaps among health sector entities. The questions ask the audience to raise their hands if their companies own or control a health insurance division; if they also employ health care providers or own clinics, specialty pharmacies, or any other medical practice or pharmacy; if they own or control a pharmacy benefit manager (PBM); and if they lead a publicly traded company at which they have a legal responsibility to maximize shareholder value. These questions are designed to surface the breadth of influence held by large health care firms. The speaker asserts that the audience’s responses demonstrate a broader pattern: the largest health insurance companies are not limited to providing insurance alone. Instead, they are also involved in delivering medical services and operating pharmacies. The speaker notes that these entities diagnose and decide treatment for patients, indicating an active role in clinical decision-making beyond underwriting risk or processing claims. Further, the speaker highlights that these same large insurers are also PBMs, describing PBMs as “another form of middlemen managing drug benefits.” This point emphasizes a layered structure in which a single company can influence which drugs are preferred, covered, or reimbursed, thereby affecting patient access and pricing across the drug supply chain. The speaker concludes that these combined roles signify that large health insurers are “increasingly controlling every aspect of our health care system.” This characterization suggests a consolidation of functions—from coverage and care provision to drug benefit management—under a few dominant corporate entities. In summary, the speaker’s lines of inquiry and subsequent claims illustrate a perceived convergence: health insurance companies are simultaneously insurers, medical providers, pharmacies, and PBMs, and they are expanding their control over multiple facets of health care delivery and economics. The overarching assertion is that the largest players in the health care landscape occupy a multifaceted, integrated position that spans diagnosis, treatment decisions, pharmacy operations, and drug benefit management, contributing to a broader phenomenon of comprehensive control within the system.

I'm your insurance company's pharmacy benefit manager. This medicine isn't covered because it's not profitable for me. Hope you feel better. Translation: I am the pharmacy benefit manager for your insurance company. This medication is not covered because it is not financially beneficial for me. I hope you feel better.

I found something interesting for Elon and the Doge team regarding Medicare. In 2022, Medicare filled 85,000 prescriptions for Perfinidone at $8,000 each, totaling $680 million. At my cost-plus pharmacy, the same prescription is only $200. Filling all 85,000 prescriptions with me would only cost $17 million. Medicare is overpaying by $663 million annually because Pharmacy Benefits Managers (PBMs) get a percentage of the cost, incentivizing them to inflate prices. The easy solution is to cancel the PBM contracts and use actual costs. If you want to check if PBMs have been raising the cost of your medications, go to forestparkpharmacy.com and check our price to see how much you could save.

A businessman told the speaker that the same fat shot drug cost him $88 in London, but $1,300 in New York. He was stunned that the identical pill, made in the same plant by the same company, had such different prices. The speaker discussed this with drug company representatives. They argued for about half an hour, but ultimately the representative admitted there was no justification for the price difference.

We currently only have a single dose available, not the 75 needed. The insurance won't cover the dosing we have. The prescription was canceled without notification, leaving the patient without medication. The other pharmacist was uncomfortable with the dosing issue, and we also lack sufficient medication. When medications are unavailable, it's important to contact another pharmacy, and for dosing issues, reach out to the doctor. Neither of these steps were taken, leaving the patient in a potentially serious situation.

Brenzavvy, a drug similar to Jardiance or Farxiga, is not covered by insurance, prescribed by doctors, or carried by wholesalers because it is too cheap. Brenzavvy costs $60 at the speaker's pharmacy. Pharmacy benefits managers (PBMs) deny coverage because Brenzavvy's low price prevents rebates. Farxiga and Jardiance cost insurance payers $1,000 upfront with a 40% rebate. An HHS report stated PBMs get 23% on average for brand meds. After rebates, Farxiga and Jardiance still cost $600, with PBMs earning $138. With 8,000,000 prescriptions a year, PBMs make $1,100,000,000 off those two drugs. The speaker claims PBMs keep Brenzavvy off their lists to avoid losing a billion dollars annually. The speaker believes affordable healthcare is impossible with PBMs involved. The speaker encourages listeners to use forestpark.pharmacy to save money and to inform their bosses about potential savings.

Speaker 1 questions the trustworthiness of Pfizer due to their history of criminal fines and unethical practices. They ask how it is considered anti-science to question a company that has been caught bribing physicians and manipulating test results, resulting in a $2.3 billion fine. Speaker 0 acknowledges the comment but asks to continue the presentation before addressing the questions. Speaker 1 insists that their questions won't be answered and mentions having four questions. Speaker 0 tries to locate a lost ring. The transcript ends abruptly.

Speaker 0 confronts a pharmacist about their son's hospitalization due to myocarditis after receiving a COVID jab. Speaker 0 is upset that his wife was not informed about this potential side effect. Speaker 1 explains that they may not disclose the side effect to avoid scaring parents away from vaccinating their children. Speaker 0 expresses disbelief and insists that parents should be given accurate information to make informed decisions.

Speaker 0 and Speaker 1 exchange a tense, fragmented interaction in a waiting room scenario. Speaker 0 expresses frustration about waiting two hours for a specialist and acknowledges the overall overload in healthcare, the low pay, and the sometimes rude behavior they perceive, while emphasizing that their own intent is simply to know when the doctor will arrive. Speaker 1 reassures that the doctor is on the way and asks for a little more patience, noting they are currently working amid the same pressures. Speaker 0 seeks a rough estimate of the doctor’s arrival time, to which Speaker 1 responds that they are busy with work. Speaker 0 again tries to engage, and Speaker 1 shifts to a broader complaint, stating that they are trying to do their job despite enormous workload, low pay, and sometimes quite rude behavior. Speaker 0 acknowledges understanding but reiterates the two-hour wait. Speaker 1 interrupts Speaker 0 to continue making a point about the environment, saying, “Luister eens, wij proberen gewoon ons werk te doen. Ondanks de enorme werkdruk in de zorg. Ondanks de lage beloningen, ondanks de soms nogal onbeschofte” (Listen, we are simply trying to do our jobs, despite the enormous workload in healthcare, despite the low pay, despite the sometimes rather rude). Speaker 0 again mentions the two-hour wait. Speaker 1 then brings up aggression they have faced, including verbal abuse and physical aggression, stating, “Ondanks alle agressie die wij over ons heen krijgen. De scheldpartijen, de fysieke” (Despite all the aggression we receive, the swearing, the physical). Speaker 0 denies being aggressive and clarifies that they only want to know roughly when the doctor will have time. The exchange intensifies as Speaker 1 accuses Speaker 0 of having an aggressive tone and warns that if Speaker 0 does not sit calmly, they will call security. Speaker 0 protests that there is nothing wrong with their tone, recounting the two-hour wait, and Speaker 1 reiterates concerns about tone, insisting that Speaker 0’s tone is not acceptable. Speaker 1 ultimately declares that enough is enough and that aggression toward care workers must end, concluding with “Handen af ten zorg. Toch?” (Hands off the care, right?) and a momentary pause that implies security involvement. The interaction centers on a stressful delay in care, the pressures faced by healthcare workers, and a conflict over tone and boundaries amid a high-demand, high-stress environment.

A businessman told the speaker that the same fat shot drug cost him $88 in London but $1,300 in New York. The drugs were identical, made in the same plant by the same company. The speaker discussed this with a representative from the drug companies, who admitted there was no justification for the price difference.

We're paying too much for drugs compared to other countries, and existing laws make it hard to lower costs. The middlemen in the drug industry are profiting significantly without adding value. We're going to eliminate these middlemen to reduce drug prices to unprecedented levels. This topic dominated our discussions with executives and others involved.

Medicare overspent on dimethyl fumarate in 2022, paying $590 million for a drug I offer at $65 per prescription. This discrepancy highlights how Pharmacy Benefits Managers (PBMs) inflate drug costs to increase their profits. Medicare's PBM charged them $3,800 per prescription when the real price is only $65. This PBM price gouging cost Medicare $580 million on just this one drug. The solution is simple: eliminate PBM contracts to save money. Also, your insurance likely uses a PBM, overcharging you too. Check if you're overpaying for your medications at fourthparkpharmacy.com to use our price checker.

Speaker 0: The pharmacy benefit managers. Speaker 1: Think of it like this. So you go to a restaurant and you order a burger. Okay? And let's say that burger costs $15. But before your order goes through, some guy steps in and says, hold on. If the restaurant wants to sell you that burger, they need to pay me $5. And if not, you can't have the burger. Speaker 0: Think of them as the toll bridge between you and drug prices. Speaker 1: But the PBM isn't just collecting the toll. They're also controlling which cars can pass. They own the bridge. They set the price of gas. They use their contracts to profit off of everyone crossing. Speaker 1: So the PBM charges the employer a very high price. It pays the pharmacy a very low price, and it keeps the difference, and that's called spread pricing.

A person confronts a pharmacist about their child developing myocarditis after receiving a COVID vaccine. The person is upset that the pharmacist did not inform them about the potential side effects. The pharmacist explains that they don't want to scare parents and that the benefits of vaccination outweigh the risks. The person argues that no healthy children have died from COVID and accuses the pharmacist of not warning people about the dangers. The conversation becomes heated and the person threatens legal action. The pharmacist maintains that they cannot make decisions about what information to provide. The conversation ends with the person expressing anger and frustration towards the pharmacist.

A common asthma drug costs almost $500 in America, but less than $40 in The United Kingdom. The speaker highlights the significant price difference, noting one person paid a small amount for the same shot in the UK. The weight loss drug Ozempic costs 10 times more in The United States than in the rest of the developed world, according to the speaker, who questions the reason for this disparity.

I've identified wasteful spending in Medicare, specifically with generic Cialis, or Tadalafil. In 2022, Medicare spent $237 million on this drug, averaging $481 per prescription across 492,000 prescriptions. However, at my pharmacy, the same prescription costs only $14 without insurance. That means it would only cost $7 million to cover the entire country at my pharmacy's pricing. The overcharge of $230 million for just this one drug is due to pharmacy benefits managers (PBMs). PBMs manage all pharmacy-related aspects for Medicare, deciding coverage, copays, government costs, and pharmacy payments. They've essentially decided on a 3000% markup. It's time to fire the PBMs and bring prices back to reality. To check the markups on your prescriptions, visit forestparkpharmacy.com and use our price checker.

The FTC sued the largest three PBMs. The FTC accuses these three companies for artificial inflating insulin prices, investigating their rebate system. There were marked up specialty drugs for cancer, HIV, and other conditions by over $7,300,000,000. One of the companies actually countersued the FTC over false and defamatory statements. PBMs own the insurance companies, and the pharmacies. Caremark owns CVS. Express Scripts owns a home delivery pharmacy. Rx owns Optum home delivery pharmacy, so they can ship directly to your house. Control of 80% of all the medications in The US comes from three of the biggest PBMs. In reality, the PBMs are not just the middleman. Since they've merged with the insurance companies and the pharmacies, now they're the actual gatekeepers of medicine.

Speaker 0 is frustrated because another store refused to fill their prescription, while Speaker 1 explains that they don't have the medication in stock. Speaker 0 mentions Ivermectin, but Speaker 1 clarifies that they don't have it and even if they did, they couldn't fill it due to quantity restrictions and lack of FDA approval. Speaker 0 argues that Wellbutrin is also not FDA approved for smoking cessation, but Speaker 1 doesn't provide a satisfactory answer. The conversation ends with Speaker 0 expressing dissatisfaction with Speaker 1's response.

A common asthma drug costs almost $500 in America, but less than $40 in The United Kingdom. The speaker stated that an individual in the UK paid a small amount for their shot, contrasting sharply with the $500 cost in the US. The weight loss drug Ozempic costs 10 times more in The United States than in the rest of the developed world. The speaker questions the reason for this disparity.

We're continuing our investigation into Medicare overspending, and today we found Aripiprazole. In 2022, Medicare spent $1.5 billion on this drug, with 7.2 million prescriptions at an average cost of $208. However, at my pharmacy, without insurance, the same medication costs only $12. Filling all those prescriptions at my pharmacy would only cost $86 million. That means over $1.4 billion was wasted due to pharmacy benefits managers (PBMs) using inflated prices and directing patients to pharmacies they own. The solution is simple: cancel the PBM contracts, eliminate the made-up prices, and get back to reality. To see how much you've been overcharged, visit forestparkpharmacy.com and use our price checker to see your potential savings.

The speaker reports an unusually high monthly utility bill of $810 for gas and electricity, noting that neighbors in the same area have similarly expensive bills. They mention that the gas and electric company, which effectively owns the area, has been signaling through the news that bills would be higher. The speaker questions how the situation can be tolerated, expressing concern about protests and the pressure to turn off heating despite personal needs. They highlight a family situation with three children, including two nonverbal autistic children who require ongoing therapy, costing about $10,000 per year. The speaker asks whether they can continue sending their children to therapy if they must pay over $800 per month just to have heat and electricity in their home. They describe their home as a twelve hundred fifty square foot ranch brick house, noting that it is not large. The speaker emphasizes a perceived lack of accountability, asking how the company can be allowed to act this way. They state, "They are price gouging the American people." They express frustration that there seem to be no repercussions and argue that "Something has to change."

A health insurance CEO was murdered, sparking a surprising reaction among younger people, with 41% expressing support. This reflects a deep-seated anger towards insurance companies, which many believe contribute to America's chronic disease crisis by prioritizing profits over patient care. The discussion highlights the profit-driven nature of health insurance, particularly through pharmacy benefit managers (PBMs), which inflate drug prices and create barriers to necessary care. The system favors medication over preventative measures, leading to widespread chronic illness. Advocates emphasize the need for a shift towards proactive healthcare that focuses on prevention and transparency, rather than a reliance on prescription drugs. The conversation underscores the urgent need for reform in the healthcare system to prioritize patient well-being over corporate profits.

The transcript centers on a critique of Democrats and the healthcare industry, framing the Capitol Hill hearing as evidence of a coordinated effort to undermine President Trump’s health care agenda. It asserts that Democrats and “the big insurance companies” are “combining forces to sabotage president Trump on Capitol Hill,” and claims this is exemplified by coverage and clips available on the speaker’s website and social media. Key points highlighted: - Democrats, Obamacare architects, and the pharmaceutical/insurance cartel are alleged to be “working in lockstep to block president Trump’s patient first health care agenda.” - Ahead of the hearing, the speaker says Loomer Unleashed warned how the proceedings would unfold, asserting that corporate health care executives aligned with Democrats against President Trump, Congressional Republicans, and the American people. - The speaker claims Democrats deployed Obama operatives—people featured on Barack Obama’s White House website—as “experts” on health care, alongside anti-Trump radical left activists who allegedly pretended to be health care experts, to blame Republicans for the health care crisis without addressing Obamacare’s effects. - Congressional Republicans, specifically Jason Smith and Randy Feenstra, are quoted as arguing that Democrats want to cast blame elsewhere because they do not accept responsibility for Obamacare, which the speakers say was always going to be a disaster. - A clip from Speaker 1 describes the hearing as “the first of more to come examining the entire health care sector.” The stated purpose is to question some of the largest health insurers about why costs are rising and how health care can be made more affordable for all Americans, asserting that Democrats in the majority previously ignored this issue. - The speaker claims that Americans are still struggling to afford basic care, with premiums “exploding” and patients being delayed and denied care “every day.” - The hearing is said to have shown that, instead of demanding accountability, a senior Democrat reassured CEOs with the statement, “it’s not your fault,” implying the Democrats’ recognition that costs rose under Obamacare. - The claim is reiterated that, after fifteen years of a Democrat-created health system under Obamacare, prices have “only gone up, not down.” The speaker indicates there is extensive video and article coverage of the hearing available online, including numerous clips and a summary article that highlights these points. The overall narrative portrays Obamacare as a disaster, accusing Democrats of avoidance of responsibility and of manipulating the hearing to deflect blame away from policy outcomes.

I'm on day five of helping to cut waste, and today I found that Medicare is overpaying for Aripiprazole. In 2022, this medication was dispensed 7.2 million times at an average of $208 each. Medicare spent $1.5 billion in one year on this one drug. At my pharmacy, without insurance, the same medication costs $12. Filling all 7.2 million prescriptions at my price would cost $86 million. That means over $1.4 billion was wasted due to Medicare's use of pharmacy benefits managers (PBMs). PBMs use an inflated price called AWP, pretend to discount it, and then send you to their pharmacies to collect the profits. This system is easily fixed by canceling PBM contracts, ditching the made-up prices, and returning to reality. To see how much you've been overcharged, visit forestparkpharmacy.com and use our price checker.